New study aims to stop oral cancer before it starts
NCT ID NCT07090070
First seen Feb 19, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study looks at people with p53-mutated oral dysplasia (abnormal cells) and early-stage oral cancer to find the best treatment at each stage. Researchers will compare surgery versus observation for low-grade dysplasia, different surgical margins for high-grade dysplasia, and adding neck dissection for early cancer. The goal is to see which approach best prevents progression to more serious disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL EPITHELIAL DYSPLASIA (OED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vancouver General Hospital
Vancouver, British Columbia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.